Paediatric systemic lupus erythematosus: A single referral centre experience
dc.contributor.author | Atas, Bulent | |
dc.contributor.author | Bulut, Mustafa | |
dc.contributor.author | Sap, Fatih | |
dc.contributor.author | Yazar, Abdullah | |
dc.contributor.author | Akin, Fatih | |
dc.contributor.author | Poyraz, Necdet | |
dc.contributor.author | Tokgoz, Huseyin | |
dc.date.accessioned | 2024-02-23T14:41:32Z | |
dc.date.available | 2024-02-23T14:41:32Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description.abstract | In this study, the clinical and laboratory findings, management and follow-up of 32 children with paediatric systemic lupus erythematosus (pSLE) were evaluated to determine the prognostic factors in pSLE. Of the 32 patients, 25 (78.1%) were females. Age at onset of symptoms and diagnosis in the patients were 147.6 +/- 49 months and 154.3 +/- 48 months, respectively. The most common symptom on admission were joint problems, seen in 25 (78.1%) patients. Haematological alterations were seen in 25 (78.1%) cases during follow-up. Lupus nephritis was diagnosed in 10 (31.2%) patients. Malar rash was seen in a total of 12 (37.5%) patients during follow up, however it had been noted in five (15.6%) patients on admission. Antinuclear antibody and anti-dsDNA were positive in all patients and 31 (96.8%) patients, respectively. Decreased complement 3 and 4 levels were noted in 23 (71.8%) patients. Antiphospholipid antibody was studied in 27 patients and it was found to be positive in 13 (48.1%) patients. In conclusion, based on our findings, we would like to emphasize that pSLE has a large and remarkable clinical and laboratory findings. | en_US |
dc.identifier.doi | 10.5455/JPMA.61641 | |
dc.identifier.endpage | 139 | en_US |
dc.identifier.issn | 0030-9982 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 33484540 | en_US |
dc.identifier.scopus | 2-s2.0-85100325903 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 136 | en_US |
dc.identifier.uri | https://doi.org/10.5455/JPMA.61641 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/16894 | |
dc.identifier.volume | 71 | en_US |
dc.identifier.wos | WOS:000641903600019 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pakistan Medical Assoc | en_US |
dc.relation.ispartof | Journal Of The Pakistan Medical Association | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Complement | en_US |
dc.subject | Joint Involvement | en_US |
dc.subject | Paediatric Systemic Lupus Erythematosus | en_US |
dc.title | Paediatric systemic lupus erythematosus: A single referral centre experience | en_US |
dc.type | Article | en_US |